CompletedNot Applicable

Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201

United States20 participantsStarted 2016-11

Plain-language summary

The purpose of this non interventional retrospective study is to continue to collect data from patients following their completion of Protocol CLS 1003-201: "Safety and Efficacy of Suprachoroidal CLS-TA with Intravitreal Aflibercept in Subjects with Macular Edema Following Retinal Vein Occlusion" (ie, the parent study).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Completed enrollment and did not receive additional aflibercept therapy in the Parent study, CLS1003-201 Exclusion Criteria: * N/A

What they're measuring

Time to additional therapy for RVO

Timeframe: 6 months following exit from Parent study

Trial details

NCT IDNCT02956330

SponsorClearside Biomedical, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2017-04-12

View on ClinicalTrials.gov More Macular Edema trials